ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)You must be logged in to view this page.
Reaching the next level of creating novel therapies for genetic diseasesYou must be logged in to view this page.